ORLANDO (MedPage Today) — The American College of Cardiology is launching an ambitious initiative to cut the Medicare heart failure readmission rate by 20% by December 2012.
No Comments »
Filed under: General Health News
Chiltern International Limited (Chiltern), a global Clinical Research Organization (CRO) that provides clinical development and staffing services in Europe, the Americas and India and its Asian partner EPS International Co. Ltd. (EPS INTERNATIONAL), a wholly owned subsidiary of EPS Co. Ltd., a leading provider of clinical development services in the Asian region, have jointly organized [...]
No Comments »
Filed under: Pharmacy News
Zydus Pharmaceuticals announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Tablets USP, 25mg, 50mg, 100mg, and 200mg. This product is available for immediate shipment. Topiramate tablets are indicated as an initial monotherapy in patients 10 years [...]
No Comments »
Filed under: Pharmacy News
The region’s largest biotechnology association today warned that a bill under consideration by the Vermont Legislature will create the most restrictive and onerous regulatory environments for biotechnology growth and development not only in New England, but in the entire nation. Senate Bill 48, an Act Relating to the Marketing of Prescribed Products, is the focus [...]
No Comments »
Filed under: Pharmacy News
ArunA Biomedical, Inc., announced that it will make its CELL-EZ(TM) brand hMC(TM) human mesenchymal progenitor cells commercially available to the research community in mid 2009. Derived from pluripotent human embryonic stem cells, ArunA’s hMC lines will offer unique, highly proliferative uniform populations of mesenchymal cells in a feeder free monolayer culture. [...]
No Comments »
Filed under: Pharmacy News
Nile Therapeutics, Inc. (Nasdaq: NLTX), a leading company in the development of novel therapeutics for heart failure patients, announced that, in the course of reviewing the Investigational New Drug (IND) application materials that Nile submitted to the U.S. Food and Drug Administration (FDA) to support the initiation of the Company’s Phase IIb clinical trial [...]
No Comments »
Filed under: Pharmacy News
Warner Chilcott Limited (Nasdaq: WCRX) announced that its affiliate, Warner Chilcott Company Inc. has submitted a New Drug Application for WC 3016, a low-dose oral contraceptive, to the U.S. Food and Drug Administration. About Warner Chilcott Warner Chilcott is a leading specialty pharmaceutical company currently focused on the [...]
No Comments »
Filed under: Pharmacy News
Researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have identified a new marker for breast cancer metastasis called TMEM, for Tumor Microenvironment of Metastasis. As reported in the March 24 online edition of the journal Clinical Cancer Research, density of TMEM was associated with the development of distant organ metastasis via the bloodstream — the most [...]
No Comments »
Filed under: Women's Health
The April 2009 issue of the peer-reviewed journal Environmental Health Perspectives (EHP) reports on a study examining the association of chronic low-level exposure to lead and accelerated declines in cognition in women age 47 - 74 years. Study findings suggest that cumulative exposure to lead at levels likely to be experienced in community settings may [...]
No Comments »
Filed under: Women's Health
Medgenics (AIM: MEDG) is pleased to announce that the latest, encouraging results of the Company’s ongoing EPODURE Biopump Phase I/II Clinical Trial will be presented at the 45th Conference of the Israeli Society of Nephrology and Hypertension, in Israel on March 27, 2009.
No Comments »
Filed under: Pharmacy News
